341 related articles for article (PubMed ID: 9735877)
21. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
Johnston WW
Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
[TBL] [Abstract][Full Text] [Related]
23. Human monoclonal antibodies.
Kan-Mitchell J; Mitchell MS
Prog Clin Biol Res; 1989; 288():85-94. PubMed ID: 2717643
[No Abstract] [Full Text] [Related]
24. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
[TBL] [Abstract][Full Text] [Related]
25. Disialoganglioside GD2 anti-idiotypic monoclonal antibodies.
Cheung NK; Canete A; Cheung IY; Ye JN; Liu C
Int J Cancer; 1993 May; 54(3):499-505. PubMed ID: 8509225
[TBL] [Abstract][Full Text] [Related]
26. Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3.
Colcher D; Milenic D; Roselli M; Raubitschek A; Yarranton G; King D; Adair J; Whittle N; Bodmer M; Schlom J
Cancer Res; 1989 Apr; 49(7):1738-45. PubMed ID: 2924317
[TBL] [Abstract][Full Text] [Related]
27. Biodistribution and histological localization of anti-human colon cancer monoclonal antibody (MAb) 1A3: the influence of administered MAb dose on tumor uptake.
Fenwick JR; Philpott GW; Connett JM
Int J Cancer; 1989 Dec; 44(6):1017-27. PubMed ID: 2691405
[TBL] [Abstract][Full Text] [Related]
28. Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes.
Riemer AB; Förster-Waldl E; Brämswig KH; Pollak A; Zielinski CC; Pehamberger H; Lode HN; Scheiner O; Jensen-Jarolim E
Eur J Immunol; 2006 May; 36(5):1267-74. PubMed ID: 16568495
[TBL] [Abstract][Full Text] [Related]
29. Radiolocalization of human small cell lung cancer and antigen-positive normal tissues using monoclonal antibody LS2D617.
Wilson BS; Petrella E; Lowe SR; Lien K; Mackensen DG; Gridley DS; Stickney DR
Cancer Res; 1990 May; 50(10):3124-30. PubMed ID: 2159374
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity.
Thurin J; Thurin M; Kimoto Y; Herlyn M; Lubeck MD; Elder DE; Smereczynska M; Karlsson KA; Clark WM; Steplewski Z
Cancer Res; 1987 Mar; 47(5):1229-33. PubMed ID: 3815333
[TBL] [Abstract][Full Text] [Related]
31. Generation and characterization of dimeric small immunoproteins specific for neuroblastoma associated antigen GD2.
Occhino M; Raffaghello L; Burrone O; Gambini C; Pistoia V; Corrias MV; Bestagno M
Int J Mol Med; 2004 Sep; 14(3):383-8. PubMed ID: 15289889
[TBL] [Abstract][Full Text] [Related]
32. Human tumor antigens.
Reisfeld RA; Cheresh DA
Adv Immunol; 1987; 40():323-77. PubMed ID: 3591561
[No Abstract] [Full Text] [Related]
33. Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3.
Esteban JM; Colcher D; Sugarbaker P; Carrasquillo JA; Bryant G; Thor A; Reynolds JC; Larson SM; Schlom J
Int J Cancer; 1987 Jan; 39(1):50-9. PubMed ID: 3793270
[TBL] [Abstract][Full Text] [Related]
34. Intraoperative detection of occult colon cancer micrometastases using 125 I-radiolabled monoclonal antibody CC49.
Cote RJ; Houchens DP; Hitchcock CL; Saad AD; Nines RG; Greenson JK; Schneebaum S; Arnold MW; Martin EW
Cancer; 1996 Feb; 77(4):613-20. PubMed ID: 8616751
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a human-mouse chimeric antibody reactive with a human melanoma associated antigen.
Marchitto KS; Kindsvogel WR; Beaumier PL; Fine SK; Gilbert T; Levin SD; Woodhouse CS; Morgan AC
Prog Clin Biol Res; 1989; 288():101-5. PubMed ID: 2470106
[TBL] [Abstract][Full Text] [Related]
36. In vivo tumor localization using tumor-specific monkey xenoantibody, alloantibody, and murine monoclonal xenoantibody.
Stuhlmiller GM; Sullivan DC; Vervaert CE; Croker BP; Harris CC; Seigler HF
Ann Surg; 1981 Nov; 194(5):592-601. PubMed ID: 6895297
[TBL] [Abstract][Full Text] [Related]
37. Systemic interleukin-2 modulates the anti-idiotypic response to chimeric anti-GD2 antibody in patients with melanoma.
Albertini MR; Gan J; Jaeger P; Hank JA; Storer B; Schell K; Rivest T; Surfus J; Reisfeld RA; Schiller JH; Sondel PM
J Immunother Emphasis Tumor Immunol; 1996 Jul; 19(4):278-95. PubMed ID: 8877722
[TBL] [Abstract][Full Text] [Related]
38. Quantitation of the density of cell surface carbohydrate antigens on cancer cells with a sensitive cell-suspension ELISA.
Ravindranath MH; Bauer PM; Cornillez-Ty C; Garcia J; Morton DL
J Immunol Methods; 1996 Oct; 197(1-2):51-67. PubMed ID: 8890894
[TBL] [Abstract][Full Text] [Related]
39. Serological and biochemical analyses of monoclonal antibodies to human melanoma-associated antigens.
Harper JR; Bumol TF; Reisfeld RA
Hybridoma; 1982; 1(4):423-32. PubMed ID: 6208137
[TBL] [Abstract][Full Text] [Related]
40. Recombinant antibodies against ganglioside expressed on tumor cells.
Hanai N; Nakamura K; Shitara K
Cancer Chemother Pharmacol; 2000; 46 Suppl():S13-7. PubMed ID: 10950141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
